phase readout
saveNCT07573670: A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute Leukemia
NOT_YET_RECRUITINGupdated 29d ago
community read0 votes
Sponsor: The First Affiliated Hospital of Soochow University. Phase: PHASE2. Conditions: Newly Diagnosed Mixed Phenotype Acute Leukemia
view source ↗
comments(0)
5-min edit window · permanent after that